A61K 2039/6087
Polysaccharides
Official title: {Polysaccharides; Lipopolysaccharides [LPS]}
A61K2039/6087 (Polysaccharides) appears on 208 US grants and 327 published applications in this corpus.
Search patents in A61K- Granted patents
- 208
- Published applications
- 327
- Assignees
- 222
- Inventors
- 668
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 3 |
| 2003 | 2 | 7 |
| 2004 | 0 | 8 |
| 2005 | 1 | 7 |
| 2006 | 2 | 6 |
| 2007 | 2 | 7 |
| 2008 | 0 | 10 |
| 2009 | 8 | 13 |
| 2010 | 4 | 14 |
| 2011 | 4 | 13 |
| 2012 | 7 | 16 |
| 2013 | 6 | 9 |
| 2014 | 9 | 11 |
| 2015 | 17 | 21 |
| 2016 | 6 | 12 |
| 2017 | 9 | 18 |
| 2018 | 13 | 21 |
| 2019 | 13 | 16 |
| 2020 | 16 | 15 |
| 2021 | 9 | 12 |
| 2022 | 15 | 21 |
| 2023 | 13 | 17 |
| 2024 | 13 | 24 |
| 2025 | 11 | 14 |
| 2026 | 4 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for inducing immune tolerance8 Sep 2026US 12,728,155 B2Anokion SA
- Method for improving immunogenicity of protein/peptide antigen7 Jul 2026US 12,673,102 B2SinoCellTech Ltd.
- Vaccine19 May 2026US 12,629,409 B2Glaxosmithkline Biologicals SA
- Modified virus-like particles of CMV21 Apr 2026US 12,605,454 B2Saiba GmbH
- Nanoparticles for use in redirection against the tumour of a non-tumour specific immune response, based on a pre-existing immunity30 Dec 2025US 12,508,310 B2Pharmaexceed S.R.L.
- Programmably degradable hydrogels for functional molecular release1 Oct 2026US 2026/0294805 A1Georgia Tech Research Corporation
- Vaccine compositions and methods for control of foot and mouth disease10 Sep 2026US 2026/0263583 A1Indian Council of Agricultural Research
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Immunogenic Composition20 Aug 2026US 2026/0240990 A1Glaxosmithkline Biologicals SA
- Nanoparticle-based anti-mycotoxin vaccines and uses thereof30 Jul 2026US 2026/0216323 A1
Most cited
By later US patents
- Targeted and high density drug loaded polymeric materials123US 7,534,449 B2Yale University · 2009
- Process for the production of virus vaccine116US 4,659,569 AKabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo · 1987
- Saponin-antigen conjugates and the use thereof99US 5,583,112 ACambridge Biotech Corporation · 1996
- Conjugates of acid polysaccharides and complex organic substances82US 4,003,792 AMiles Laboratories, Inc. · 1977
- Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof81US 6,573,245 B1Galenica Pharmaceuticals, Inc. · 2003